Cigna, CVS, UnitedHealth PBMs sue FTC over insulin prices case
| RSECX Fund | USD 18.46 0.08 0.44% |
Slightly above 53% of Us Strategic's investor base is interested to short. The analysis of overall sentiment of trading Us Strategic Equity mutual fund suggests that many investors are impartial at this time. Us Strategic's investing sentiment can be driven by a variety of factors including economic data, Us Strategic's earnings reports, geopolitical events, and overall market trends.
RSECX |
Pharmacy benefit managers owned by Cigna, CVS Health, and UnitedHealth Group have sued the FTC over inflated insulin prices. Read more here.
Read at seekingalpha.com
 |
Us Strategic Fundamental Analysis
We analyze Us Strategic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Us Strategic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Us Strategic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Us Strategic is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Us Strategic Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Us Strategic mutual fund to make a market-neutral strategy. Peer analysis of Us Strategic could also be used in its relative valuation, which is a method of valuing Us Strategic by comparing valuation metrics with similar companies.
Peers
Us Strategic Related Equities
| RNTTX | International Developed | 1.13 | ||||
| RALAX | Growth Strategy | 0.46 | ||||
| RALUX | Growth Strategy | 0.46 | ||||
| RALCX | Growth Strategy | 0.42 | ||||
| RSBRX | Strategic Bond | 0.33 | ||||
| RSBTX | Short Duration | 0.16 | ||||
| RALRX | Growth Strategy | 0.07 | ||||
| RALVX | Growth Strategy | 0.00 | ||||
| RRSCX | Global Real | 0.24 | ||||
| RRSRX | Global Real | 0.25 |
Other Information on Investing in RSECX Mutual Fund
Us Strategic financial ratios help investors to determine whether RSECX Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RSECX with respect to the benefits of owning Us Strategic security.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |